IKK 16 - CAS 873225-46-8
Catalog number:
873225-46-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C28H29N5OS
Molecular Weight:
483.63
COA:
Inquire
Targets:
IKK
Description:
IKK16 is a selective IκB kinase (IKK) inhibitor for IKK-2( IC50=40 nM), IKK complex( IC50=70 nM) and IKK-1(IC50=2000 nM).
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Related CAS:
1186195-62-9 (HCl salt)
Appearance:
Solid powder
Synonyms:
(4-((4-(benzo[b]thiophen-2-yl)pyrimidin-2-yl)amino)phenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone; IKK-16; IKK 16; IKK16; IKK-16
MSDS:
Inquire
InChIKey:
BWZJBXAPRCVCKQ-UHFFFAOYSA-N
InChI:
1S/C28H29N5OS/c34-27(33-17-12-23(13-18-33)32-15-3-4-16-32)20-7-9-22(10-8-20)30-28-29-14-11-24(31-28)26-19-21-5-1-2-6-25(21)35-26/h1-2,5-11,14,19,23H,3-4,12-13,15-18H2,(H,29,30,31)
Canonical SMILES:
O=C(C1=CC=C(NC2=NC=CC(C3=CC4=CC=CC=C4S3)=N2)C=C1)N5CCC(N6CCCC6)CC5
1.RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway.
Murakawa Y1, Hinz M2, Mothes J3, Schuetz A4, Uhl M5, Wyler E1, Yasuda T6, Mastrobuoni G7, Friedel CC8, Dölken L9, Kempa S7, Schmidt-Supprian M10, Blüthgen N11, Backofen R5, Heinemann U12, Wolf J3, Scheidereit C2, Landthaler M1. Nat Commun. 2015 Jul 14;6:7367. doi: 10.1038/ncomms8367.
The RNA-binding protein RC3H1 (also known as ROQUIN) promotes TNFα mRNA decay via a 3'UTR constitutive decay element (CDE). Here we applied PAR-CLIP to human RC3H1 to identify ∼ 3,800 mRNA targets with >16,000 binding sites. A large number of sites are distinct from the consensus CDE and revealed a structure-sequence motif with U-rich sequences embedded in hairpins. RC3H1 binds preferentially short-lived and DNA damage-induced mRNAs, indicating a role of this RNA-binding protein in the post-transcriptional regulation of the DNA damage response. Intriguingly, RC3H1 affects expression of the NF-κB pathway regulators such as IκBα and A20. RC3H1 uses ROQ and Zn-finger domains to contact a binding site in the A20 3'UTR, demonstrating a not yet recognized mode of RC3H1 binding. Knockdown of RC3H1 resulted in increased A20 protein expression, thereby interfering with IκB kinase and NF-κB activities, demonstrating that RC3H1 can modulate the activity of the IKK/NF-κB pathway.
2.Astragaloside IV facilitates glucose transport in C2C12 myotubes through the IRS1/AKT pathway and suppresses the palmitate-induced activation of the IKK/IκBα pathway.
Zhu R1, Zheng J1, Chen L1, Gu B1, Huang S1. Int J Mol Med. 2016 Apr 11. doi: 10.3892/ijmm.2016.2555. [Epub ahead of print]
Astragaloside IV is a monomer isolated from Astragalus membranaceus (Fisch.) Bunge, which is one of the most widely used plant-derived drugs in traditional Chinese medicine for diabetes therapy. In the present study, we aimed to examine the effects of astragaloside IV on glucose in C2C12 myotubes and the underlying molecular mechanisms responsible for these effects. Four-day differentiated C2C12 myotubes were exposed to palmitate for 16 h in order to establish a model of insulin resistance and 3H glucose uptake, using 2-Deoxy‑D‑[1,2-3H(N)]-glucose (radiolabeled 2-DG), was detected. Astragaloside IV was added 2 h prior to palmitate exposure. The translocation of glucose transporter 4 (GLUT4) was evaluated by subcellular fractionation, and the expression of insulin signaling molecules such as insulin receptor β (IRβ), insulin receptor substrate (IRS)1/protein kinase B (AKT) and inhibitory κB kinase (IKK)/inhibitor-κBα (IκBα), which are associated with insulin signal transduction, were assessed in the basal or the insulin‑stimulated state using western blot analysis or RT-PCR.
3.Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1.
Cataldi M1, Shah NR1, Felt SA1, Grdzelishvili VZ2. Virology. 2015 Nov;485:340-54. doi: 10.1016/j.virol.2015.08.003. Epub 2015 Aug 29.
Vesicular stomatitis virus (VSV) is an effective oncolytic virus against most human pancreatic ductal adenocarcinoma (PDAC) cell lines. However, some PDAC cell lines are highly resistant to oncolytic VSV-ΔM51 infection. To better understand the mechanism of resistance, we tested a panel of 16 small molecule inhibitors of different cellular signaling pathways, and identified TPCA-1 (IKK-β inhibitor) and ruxolitinib (JAK1/2 inhibitor), as strong enhancers of VSV-ΔM51 replication and virus-mediated oncolysis in all VSV-resistant PDAC cell lines. Both TPCA-1 and ruxolitinib similarly inhibited STAT1 and STAT2 phosphorylation and decreased expression of antiviral genes MxA and OAS. Moreover, an in situ kinase assay provided biochemical evidence that TPCA-1 directly inhibits JAK1 kinase activity. Together, our data demonstrate that TPCA-1 is a unique dual inhibitor of IKK-β and JAK1 kinase, and provide a new evidence that upregulated type I interferon signaling plays a major role in resistance of pancreatic cancer cells to oncolytic viruses.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related IKK Products


CAS 600734-02-9 Bay 65-1942 free base

Bay 65-1942 free base
(CAS: 600734-02-9)

Bay 65-1942 is an ATP-competitive inhibitor that selectively targets IKKβ kinase.

CAS 68302-57-8 Amlexanox

Amlexanox
(CAS: 68302-57-8)

Amlexanox is a specific inhibitor of IKKε and TBK1, which inhibits IKKε and TBK1 activity as determined by MBP phosphorylation.

CAS 960293-88-3 BI605906

BI605906
(CAS: 960293-88-3)

BI605906 is a novel pharmacological inhibitors of the IKK family. It inhibits IKKβ with an IC50 value of 380 nM when assayed at 0.1 mM ATP in vitro. It also inh...

CAS 1292310-49-6 IKKε-IN-1

IKKε-IN-1
(CAS: 1292310-49-6)

IKKε-IN-1 is a potent IKKε inhibitor; inhibit the in-situ ΙKΚ ε-mediated phosphorylation of IRF3 with an IC50 value of less than about 100 nM.

CAS 946518-61-2 LY2409881

LY2409881
(CAS: 946518-61-2)

LY2409881 is a novel selective inhibitor of IKK2. It inhibited constitutively activated NF-κB, and caused concentration- and time-dependent growth inhibition an...

CAS 873225-46-8 IKK 16

IKK 16
(CAS: 873225-46-8)

IKK16 is a selective IκB kinase (IKK) inhibitor for IKK-2( IC50=40 nM), IKK complex( IC50=70 nM) and IKK-1(IC50=2000 nM).

CAS 600734-06-3 Bay 65-1942 hydrochloride

Bay 65-1942 hydrochloride
(CAS: 600734-06-3)

Bay 65-1942 hydrochloride is an ATP-competitive inhibitor that selectively targets IKKβ kinase.

CAS 445430-58-0 BMS-345541

BMS-345541
(CAS: 445430-58-0)

BMS-345541 is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM, respectively.

CAS 783348-36-7 MLN120B

MLN120B
(CAS: 783348-36-7)

MLN120B is a potent and effective IKKbeta inhibitor. It is currently being explored for treatment of inflammatory diseases such as COPD and asthma.

MRT67307 HCl

MRT67307 is a potent and dual IKKϵ and TBK1 inhibitor with IC50 of 160 and 19 nM, respectively. It is an inhibitor for ULK1and ULK2 with IC50 value of 45 and 38...

CAS 547757-23-3 BMS-345541

BMS-345541
(CAS: 547757-23-3)

BMS-345541 is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1. It exhibits no effect against a panel of 15 other kinases and attenuate...

CAS 406209-26-5 IKK-2 inhibitor VIII

IKK-2 inhibitor VIII
(CAS: 406209-26-5)

IKK-2 inhibitor VIII is a potent and selective IKK-2 inhibitor.

CAS 862812-98-4 IKK-3 Inhibitor

IKK-3 Inhibitor
(CAS: 862812-98-4)

IKK-3 Inhibitor is a potent, selective, inhibitor of IKK-epsilon kinase and is inactive at IKK-α and IKK-β.

CAS 946518-60-1 LY2409881

LY2409881
(CAS: 946518-60-1)

LY2409881 is a potent and selective IKK2 inhibitor with IC50 of 30 nM, >10-fold selectivity over IKK1 and other common kinases.

CAS 507475-17-4 TPCA-1

TPCA-1
(CAS: 507475-17-4)

TPCA-1 is an inhibitor of IKK-2 with IC50 of 17.9 nM, inhibits NF-κB pathway, exhibits 22-fold selectivity over IKK-1.

CAS 978-62-1 IMD 0354

IMD 0354
(CAS: 978-62-1)

IMD-0354 is an IKKβ inhibitor and blocks IκBα phosphorylation in NF-κβ pathway.

CAS 354812-17-2 SC-514

SC-514
(CAS: 354812-17-2)

SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 μM, blocks NF-κB-dependent gene expression, does not inhibit other IKK isoforms or...

CAS 758683-21-5 Bay 65-1942 R form

Bay 65-1942 R form
(CAS: 758683-21-5)

Bay 65-1942 R form is an ATP-competitive inhibitor that selectively targets IKKβ kinase.

AZD3264
(CAS: 1609281-86-8)

AZD3264 is a novel IKK2 inhibitor.

CAS 19542-67-7 BAY 11-7082

BAY 11-7082
(CAS: 19542-67-7)

BAY 11-7082 completely and specifically abrogates NF-κB DNA binding, downregulating the NF-κB-inducible cytokine IL-6 and inducing apoptosis.

Chemical Structure

CAS 873225-46-8 IKK 16

Quick Inquiry

Verification code

Featured Items